Angiosarcoma: Difference between revisions
Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
'''Angiosarcoma''' is a rare malignant vascular neoplasm of endothelial-type cells that line vessel walls. | |||
==Historical Perspective== | ==Historical Perspective== |
Revision as of 19:10, 21 April 2016
WikiDoc Resources for Angiosarcoma |
Articles |
---|
Most recent articles on Angiosarcoma Most cited articles on Angiosarcoma |
Media |
Powerpoint slides on Angiosarcoma |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Angiosarcoma at Clinical Trials.gov Clinical Trials on Angiosarcoma at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Angiosarcoma
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Angiosarcoma Discussion groups on Angiosarcoma Patient Handouts on Angiosarcoma Directions to Hospitals Treating Angiosarcoma Risk calculators and risk factors for Angiosarcoma
|
Healthcare Provider Resources |
Causes & Risk Factors for Angiosarcoma |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Synonyms and keywords: Hemangiosarcoma; Pulmonary angiosarcoma; Vascular sarcoma
Overview
Angiosarcoma is a rare malignant vascular neoplasm of endothelial-type cells that line vessel walls.
Historical Perspective
- Angiosarcoma was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
Classification
- Angiosarcoma may be classified according to [classification method] into [number] subtypes/groups:
- Other variants of angiosarcoma include [disease subtype 1], [disease subtype 2], and [disease subtype 3].
Pathophysiology
- The pathogenesis of angiosarcoma is characterized by [feature1], [feature2], and [feature3].
- The [gene name] gene/Mutation in [gene name] has been associated with the development of angiosarcoma, involving the [molecular pathway] pathway.
- On gross pathology, characteristic findings of angiosarcoma, may include:
- On microscopic histopathological analysis, characteristic findings of angiosarcoma, may include:
Causes
- Common causes of angiosarcoma may include:
Differentiating angiosarcoma from other Diseases
- Angiosarcoma must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
- [Differential dx1]
- [Differential dx2]
- [Differential dx3]
Epidemiology and Demographics
- The prevalence of angiosarcoma is approximately [number or range] per 100,000 individuals worldwide.
- In [year], the incidence of angiosarcoma was estimated to be [number or range] cases per 100,000 individuals in [location].
Age
- Patients of all age groups may develop angiosarcoma.
- Angiosarcoma is more commonly observed among patients aged [age range] years old.
- Angiosarcoma is more commonly observed among [elderly patients/young patients/children].
Gender
- Angiosarcoma affects men and women equally.
- [Gender 1] are more commonly affected with angiosarcoma than [gender 2].
- The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
Race
- There is no racial predilection for angiosarcoma.
- Angiosarcoma usually affects individuals of the [race 1] race.
- [Race 2] individuals are less likely to develop angiosarcoma.
Risk Factors
- Common risk factors in the development of angiosarcoma are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Natural History, Complications and Prognosis
- The majority of patients with angiosarcoma remain asymptomatic for [duration/years].
- Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
- If left untreated, [#%] of patients with angiosarcoma may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
- Common complications of angiosarcoma include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with angiosarcoma is approximately [#%].
Diagnosis
Diagnostic Criteria
- The diagnosis of angiosarcoma is made when at least [number] of the following [number] diagnostic criteria are met:
- [criterion 1]
- [criterion 2]
- [criterion 3]
- [criterion 4]
Symptoms
- Angiosarcoma is usually asymptomatic.
- Symptoms of angiosarcoma may include the following:
- [symptom 1]
- [symptom 2]
- [symptom 3]
- [symptom 4]
- [symptom 5]
- [symptom 6]
Physical Examination
- Patients with angiosarcoma usually appear [general appearance].
- Physical examination may be remarkable for:
- [finding 1]
- [finding 2]
- [finding 3]
- [finding 4]
- [finding 5]
- [finding 6]
Laboratory Findings
- There are no specific laboratory findings associated with angiosarcoma.
- A [positive/negative] [test name] is diagnostic of angiosarcoma.
- An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of angiosarcoma.
- Other laboratory findings consistent with the diagnosis of angiosarcoma include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
Imaging Findings
- There are no [imaging study] findings associated with angiosarcoma.
- [Imaging study 1] is the imaging modality of choice for angiosarcoma.
- On [imaging study 1], angiosarcoma is characterized by [finding 1], [finding 2], and [finding 3].
- [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
- Angiosarcoma may also be diagnosed using [diagnostic study name].
- Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
Treatment
Medical Therapy
- There is no treatment for angiosarcoma; the mainstay of therapy is supportive care.
- The mainstay of therapy for angiosarcoma is [medical therapy 1] and [medical therapy 2].
- [Medical therapy 1] acts by [mechanism of action1].
- Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
Surgery
- Surgery is the mainstay of therapy for angiosarcoma.
- [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of angiosarcoma.
- [Surgical procedure] can only be performed for patients with [disease stage] angiosarcoma.
Prevention
- There are no primary preventive measures available for angiosarcoma.
- Effective measures for the primary prevention of angiosarcoma include [measure1], [measure2], and [measure3].
- Once diagnosed and successfully treated, patients with angiosarcoma are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].